Cytochroma manufacture genetically diverse stem cell-derived models to predict the safety and effect of drugs in a global population. Cytochroma’s automated cell manufacture, physiologically relevant models and rapid screening platform makes preclinical testing faster, safer and smarter.
Qualus is a provider of sustainable solutions for the leather industry, focusing on reducing the environmental impact of leather tanneries. The company has developed innovative technology that utilizes small polymer granules, known as Sferes, to help tanneries conserve water, lower production costs, and enhance the quality of their leather products. By implementing this technology, tanneries can decrease their energy consumption and carbon footprint, contributing to a more sustainable manufacturing process. Recently, Qualus secured £1 million in financing, with backing from Irrus Investments and other co-investors, to further advance its mission of promoting sustainability within the leather sector.
Cambridge GaN Devices is a developer of semiconductors focused on designing, creating, and commercializing gallium nitride-based power devices. The company's transistors offer higher speed, significantly lower power loss, and reduced size compared to traditional silicon alternatives. These advancements result in lower energy consumption and enhanced power storage and conversion capabilities. As a result, Cambridge GaN Devices provides industries with compact semiconductors tailored for critical applications across various market segments.
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry. The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver.
SupaPass is a comprehensive platform that enables businesses to create their own websites and mobile applications without needing technical expertise. Founded in 2011, SupaPass offers an innovative white-label solution that allows clients to launch payment-ready content-driven websites and apps quickly and affordably. The platform is designed to meet the needs of various sectors including podcasting, fitness, music, and charities, providing users with tools to manage content such as podcasts, videos, and streaming channels in a manner similar to popular services like Netflix. By utilizing SupaPass, clients maintain full ownership of customer data and retain 100% of their sales, all while benefiting from a more cost-effective and efficient alternative to custom-built solutions. The platform empowers content owners to engage directly with their audiences, facilitating a regular revenue stream and enhancing their brand presence online.
SupaPass is a comprehensive platform that enables businesses to create their own websites and mobile applications without needing technical expertise. Founded in 2011, SupaPass offers an innovative white-label solution that allows clients to launch payment-ready content-driven websites and apps quickly and affordably. The platform is designed to meet the needs of various sectors including podcasting, fitness, music, and charities, providing users with tools to manage content such as podcasts, videos, and streaming channels in a manner similar to popular services like Netflix. By utilizing SupaPass, clients maintain full ownership of customer data and retain 100% of their sales, all while benefiting from a more cost-effective and efficient alternative to custom-built solutions. The platform empowers content owners to engage directly with their audiences, facilitating a regular revenue stream and enhancing their brand presence online.
Lightpoint Medical, Ltd., a medical device company, develops imaging technologies for cancer surgery. It develops Cerenkov Luminescence Imaging technology that detects cancer in real-time during surgery, and reduces the likelihood of cancer recurrence and the need for reoperation. Lightpoint Medical, Ltd. was formerly known as Artemis Diagnostics Ltd. and changed its name to Lightpoint Medical, Ltd. in January 2013. The company was founded in 2012 and is based in Rickmansworth, United Kingdom.
Sorex Sensors Limited specializes in the design and manufacturing of film bulk acoustic resonator (FBAR) technology-based micro-electro-mechanical system (MEMS) mass sensors for both industrial and consumer applications. The sensors are constructed on silicon wafers and utilize a thin film of piezoelectric material, enabling them to measure mass by detecting changes in resonant frequency when mass is applied to their surface. These sensors are characterized by their dual-mode capability, allowing simultaneous measurement of mass and temperature, with mass sensitivity reaching the femtogram range and temperature resolution down to 0.2 °C. Their compact size and low power consumption make them suitable for various applications, including thin film metrology, particulate monitoring, and gas detection. Sorex Sensors was incorporated in 2017 and is headquartered in the United Kingdom.
SupaPass is a comprehensive platform that enables businesses to create their own websites and mobile applications without needing technical expertise. Founded in 2011, SupaPass offers an innovative white-label solution that allows clients to launch payment-ready content-driven websites and apps quickly and affordably. The platform is designed to meet the needs of various sectors including podcasting, fitness, music, and charities, providing users with tools to manage content such as podcasts, videos, and streaming channels in a manner similar to popular services like Netflix. By utilizing SupaPass, clients maintain full ownership of customer data and retain 100% of their sales, all while benefiting from a more cost-effective and efficient alternative to custom-built solutions. The platform empowers content owners to engage directly with their audiences, facilitating a regular revenue stream and enhancing their brand presence online.
Featurespace is the world-leader in Adaptive Behavioural Analytics and creator of the ARIC™ platform, a machine learning software system developed out of the University of Cambridge. The ARIC™ platform uses anomaly detection to analyse complex behavioural data in real time, spotting anomalies to block new fraud attacks as they occur. At the same time, Featurespace recognises genuine customers without blocking their activity. ARIC™ reduces the number of genuine transactions incorrectly identified as fraud by over 70%, enabling businesses to accept more revenue.
Head quartered in Cambridge, UK, and Atlanta, GA, U.S. Featurespace has deployed the ARIC™ platform to organisations that have services or products deployed in over 180 countries. Customers include Betfair, Vocalink/Zapp, Worldpay, and TSYS, the largest third-party processor of Visa® and MasterCard® credit cards in the U.S.
DefiniGEN Limited specializes in providing human cell products for the life sciences and drug discovery sectors. The company's offerings include various types of human hepatocytes and pancreatic cells, which are essential for research on conditions such as diabetes, hepatitis, hypercholesterolemia, and glycogen storage diseases. DefiniGEN has developed a unique platform for producing induced pluripotent stem cells (iPSCs), enabling it to create highly predictive in vitro cell products that enhance drug discovery processes for pharmaceutical companies. In addition to its cell products, the company offers services such as custom cell production, compound profiling, gene-editing, and iPS differentiation. Established in 2011 and based in Cambridge, UK, DefiniGEN draws on the expertise and intellectual property developed at the University of Cambridge, particularly in regenerative medicine and metabolic disease modeling.
Spectral Edge Ltd is a technology company based in Cambridge, United Kingdom, specializing in image enhancement and video personalization technologies. Founded in 2011, the company has developed patented image fusion technology that utilizes deep learning to improve image quality and visibility, particularly for color-blind individuals. Its flagship products include Phusion, which enhances images and videos by leveraging information beyond the normal visible spectrum, Eyeteq, designed to make television content more accessible to those with color vision deficiencies, and Nighteq, which reduces blue light to enhance sleep quality while maintaining visual contrast. These innovations find applications in various sectors, including computational photography, security, and consumer electronics, serving manufacturers and service providers in enhancing the viewing experience. As of December 2019, Spectral Edge operates as a subsidiary of Apple Inc.
SupaPass is a comprehensive platform that enables businesses to create their own websites and mobile applications without needing technical expertise. Founded in 2011, SupaPass offers an innovative white-label solution that allows clients to launch payment-ready content-driven websites and apps quickly and affordably. The platform is designed to meet the needs of various sectors including podcasting, fitness, music, and charities, providing users with tools to manage content such as podcasts, videos, and streaming channels in a manner similar to popular services like Netflix. By utilizing SupaPass, clients maintain full ownership of customer data and retain 100% of their sales, all while benefiting from a more cost-effective and efficient alternative to custom-built solutions. The platform empowers content owners to engage directly with their audiences, facilitating a regular revenue stream and enhancing their brand presence online.
Arquer Diagnostics Ltd. specializes in the design, development, and commercialization of non-invasive immunoassay diagnostic tests for bladder and prostate cancer. The company offers an enzyme-linked immunosorbent assay (ELISA) for measuring small amounts of substances in body fluids, including a CE-marked ELISA kit for Mcm5, which is utilized in hospital pathology laboratories. Additionally, Arquer provides a point-of-care system that features a robust reader instrument and disposable cartridges, allowing for immediate testing in urology clinics, hospital laboratories, and general practitioners' surgeries. Founded in 2005 and formerly known as UroSens Ltd., the company is headquartered in Sunderland, United Kingdom, and is committed to improving cancer detection and monitoring to enhance patient outcomes.
Lightpoint Medical, Ltd., a medical device company, develops imaging technologies for cancer surgery. It develops Cerenkov Luminescence Imaging technology that detects cancer in real-time during surgery, and reduces the likelihood of cancer recurrence and the need for reoperation. Lightpoint Medical, Ltd. was formerly known as Artemis Diagnostics Ltd. and changed its name to Lightpoint Medical, Ltd. in January 2013. The company was founded in 2012 and is based in Rickmansworth, United Kingdom.
SupaPass is a comprehensive platform that enables businesses to create their own websites and mobile applications without needing technical expertise. Founded in 2011, SupaPass offers an innovative white-label solution that allows clients to launch payment-ready content-driven websites and apps quickly and affordably. The platform is designed to meet the needs of various sectors including podcasting, fitness, music, and charities, providing users with tools to manage content such as podcasts, videos, and streaming channels in a manner similar to popular services like Netflix. By utilizing SupaPass, clients maintain full ownership of customer data and retain 100% of their sales, all while benefiting from a more cost-effective and efficient alternative to custom-built solutions. The platform empowers content owners to engage directly with their audiences, facilitating a regular revenue stream and enhancing their brand presence online.
PneumaCare Limited specializes in the development of non-invasive systems for assessing and monitoring lung function, particularly in vulnerable populations such as infants, intensive care patients, and the elderly. The company's primary product, PneumaScan, utilizes structured light plethysmography to capture motion and assess thoraco-abdominal volume without requiring direct contact with patients. This innovative approach allows for natural breathing assessments and spirometric maneuvers, thereby minimizing discomfort and infection risk associated with traditional spirometry. PneumaCare's product line includes various models such as Thora-3Di, Thora-3Di Infant, and Thora3Di Remote, which are designed for diverse clinical applications. Founded in 2008 and based in Ely, United Kingdom, PneumaCare's technology is supported by research from the University of Cambridge and is currently being evaluated in clinical settings, including prominent hospitals in Cambridge and London.
Eagle Genomics Ltd. specializes in providing data management and analysis solutions for the healthcare, pharmaceutical, biotech, and personal care sectors. Founded in 2008 and based in Cambridge, United Kingdom, with additional offices in the United States, Germany, and India, the company focuses on the management and analysis of genomic data, particularly through next-generation sequencing technologies. Its services encompass NGS data management, analysis, visualization, biomarker discovery, and custom software development. The company also offers pipeline design services and a web-based platform, ElasticAP, for managing life sciences research and development data in the cloud. With a unique blend of expertise in biology, bioinformatics, data science, and software engineering, Eagle Genomics helps clients in drug development, personal hygiene, and agri-tech industries maximize the value of their research and development data, addressing challenges associated with the increasing volume of life sciences data.
SwiftKey is a technology company based in London, United Kingdom, founded in 2008 by Ben Medlock and Jon Reynolds. The company specializes in developing a smart and customizable keyboard application that enhances typing efficiency on mobile devices. By utilizing artificial intelligence, SwiftKey's software learns from individual users to provide accurate auto-corrections and next-word predictions based on the context of their writing. The SwiftKey Keyboard supports over 80 languages, making it accessible to a diverse global audience. Through its innovative approach, SwiftKey aims to improve the interaction between keyboards and users, ultimately facilitating faster and more intuitive typing experiences.
Cambridge Communication Systems Limited is a technology company based in Cambridge, United Kingdom, established in 2010. The company specializes in designing and developing self-organizing wireless backhaul solutions tailored for various applications, including small cell deployments, Wi-Fi networks, CCTV, smart cities, and enterprise access. Its flagship products include Metnet, a self-organizing 5G microwave backhaul system, and the Metnet SON Multipoint solution, which operates in the 24/26/28GHz frequency range. Cambridge Communication Systems aims to deliver cost-effective and efficient backhaul solutions to enhance mobile infrastructure.
Featurespace is the world-leader in Adaptive Behavioural Analytics and creator of the ARIC™ platform, a machine learning software system developed out of the University of Cambridge. The ARIC™ platform uses anomaly detection to analyse complex behavioural data in real time, spotting anomalies to block new fraud attacks as they occur. At the same time, Featurespace recognises genuine customers without blocking their activity. ARIC™ reduces the number of genuine transactions incorrectly identified as fraud by over 70%, enabling businesses to accept more revenue.
Head quartered in Cambridge, UK, and Atlanta, GA, U.S. Featurespace has deployed the ARIC™ platform to organisations that have services or products deployed in over 180 countries. Customers include Betfair, Vocalink/Zapp, Worldpay, and TSYS, the largest third-party processor of Visa® and MasterCard® credit cards in the U.S.
Cambridge Communication Systems Limited is a technology company based in Cambridge, United Kingdom, established in 2010. The company specializes in designing and developing self-organizing wireless backhaul solutions tailored for various applications, including small cell deployments, Wi-Fi networks, CCTV, smart cities, and enterprise access. Its flagship products include Metnet, a self-organizing 5G microwave backhaul system, and the Metnet SON Multipoint solution, which operates in the 24/26/28GHz frequency range. Cambridge Communication Systems aims to deliver cost-effective and efficient backhaul solutions to enhance mobile infrastructure.
SwiftKey is a technology company based in London, United Kingdom, founded in 2008 by Ben Medlock and Jon Reynolds. The company specializes in developing a smart and customizable keyboard application that enhances typing efficiency on mobile devices. By utilizing artificial intelligence, SwiftKey's software learns from individual users to provide accurate auto-corrections and next-word predictions based on the context of their writing. The SwiftKey Keyboard supports over 80 languages, making it accessible to a diverse global audience. Through its innovative approach, SwiftKey aims to improve the interaction between keyboards and users, ultimately facilitating faster and more intuitive typing experiences.
Arachnys Information Services Limited, founded in 2010 and based in Cambridge, United Kingdom, specializes in developing cloud-based solutions that enhance the assessment of financial crime risks and compliance with customer due diligence, know your customer, and enhanced due diligence regulations. The company offers a web crawler and deep-web search engine that enables access to hard-to-reach information, particularly from emerging markets such as India, China, Russia, and the Middle East. Arachnys addresses the challenges posed by fragmented and disorganized data in these regions by employing advanced spidering and scraping technology, which allows businesses to extract valuable insights from siloed corporate and governmental datasets. Its services cater to investment banks, hedge funds, law firms, accountants, and risk consultancies seeking growth opportunities in complex markets while minimizing associated risks.
PneumaCare Limited specializes in the development of non-invasive systems for assessing and monitoring lung function, particularly in vulnerable populations such as infants, intensive care patients, and the elderly. The company's primary product, PneumaScan, utilizes structured light plethysmography to capture motion and assess thoraco-abdominal volume without requiring direct contact with patients. This innovative approach allows for natural breathing assessments and spirometric maneuvers, thereby minimizing discomfort and infection risk associated with traditional spirometry. PneumaCare's product line includes various models such as Thora-3Di, Thora-3Di Infant, and Thora3Di Remote, which are designed for diverse clinical applications. Founded in 2008 and based in Ely, United Kingdom, PneumaCare's technology is supported by research from the University of Cambridge and is currently being evaluated in clinical settings, including prominent hospitals in Cambridge and London.
Augmentra Ltd, based in Cambridge, United Kingdom, specializes in outdoor navigation through its flagship product, ViewRanger. Founded in 2006, ViewRanger is a GPS navigation software application that assists users in planning, navigating, recording, and sharing outdoor adventures such as walking, hiking, and biking. The application incorporates augmented reality features and serves millions of active users seeking to enhance their outdoor experiences. As of May 2020, Augmentra operates as a subsidiary of Outdooractive GmbH.
Enval Limited, founded in 2005 and based in Huntingdon, United Kingdom, specializes in recycling equipment and modular plants designed for the recycling of plastic-aluminium laminates using microwave-induced pyrolysis. Originally a spin-out from the Department of Chemical Engineering at the University of Cambridge, the company focuses on offering innovative solutions to address environmental and regulatory challenges across various sectors, including industrial, commercial, and municipal. Enval provides environmental life cycle analysis and technology consultancy, specifically targeting the pyrolytic recycling of complex flexible packaging materials. Its clients include waste handlers, local authorities, fast-moving consumer goods brands, and individual consumers, all benefiting from Enval's expertise in delivering value from waste.
Phico Therapeutics Limited operates as a biotechnology company that primarily focuses on developing antibiotics to overcome antibacterial resistance. Its SASPject platform delivers anti-bacterial proteins, such as small acid-soluble spore proteins to selected bacterial species using targetable non-delivery vehicles. The company’s portfolio includes SASPject PT3, an antibiotic against Pseudomonas aeruginosa; SASPject PT4 and SASPject PT5 for systemic use against Klebsiella pneumonia and Escherichia coli; and SASPject PT1.2 that targets Staphylococcus aureus. Phico Therapeutics Limited was incorporated in 2000 and is based in Bourn, United Kingdom.
Nujira specializes in power amplifier technology for the wireless communications industry, focusing on high-efficiency solutions for 3G and fourth-generation cellular terminals, as well as digital broadcast transmitters. The company is known for its High Accuracy Tracking (HAT) Power Modulators, which help equipment manufacturers create smaller, more affordable, and energy-efficient base stations and transmitters. With a strong emphasis on envelope tracking technology, Nujira addresses the growing demands of operators and broadcasters by enhancing the performance and efficiency of broadband RF power amplifiers. The company holds over 200 patents related to envelope tracking, underscoring its commitment to innovation in the sector.
Metalysis Limited is a technology company based in Rotherham, United Kingdom, specializing in the manufacture of high-value metals and alloys, particularly titanium and tantalum. Founded in 2001, the company utilizes a solid-state process originally developed at the University of Cambridge to produce metal alloy powders that are primarily used in advanced manufacturing, aerospace, and automotive applications. This innovative process is designed to be more environmentally friendly and energy-efficient than traditional melting methods, providing clients with lower-cost solutions for producing 3D printable metal powders. Metalysis has established collaborations with various industrial and academic partners to enhance its production capabilities, including the Generation 4 technological expansion, which aims to scale up production to meet industrial demands. In addition to its manufacturing services, Metalysis also offers powder metallurgy, additives, and analytical services.
Nujira specializes in power amplifier technology for the wireless communications industry, focusing on high-efficiency solutions for 3G and fourth-generation cellular terminals, as well as digital broadcast transmitters. The company is known for its High Accuracy Tracking (HAT) Power Modulators, which help equipment manufacturers create smaller, more affordable, and energy-efficient base stations and transmitters. With a strong emphasis on envelope tracking technology, Nujira addresses the growing demands of operators and broadcasters by enhancing the performance and efficiency of broadband RF power amplifiers. The company holds over 200 patents related to envelope tracking, underscoring its commitment to innovation in the sector.
Kaptivo uses AI to make visual collaboration easier and more efficient. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. Businesses and schools use Kaptivo in conjunction with Zoom, Cisco Webex, Microsoft Teams, Slack and other collaboration tools to improve productivity while keeping content secure.
Ubisense is the world leader in Precise Real-Time Location Systems, providing enterprise business automation by tracking people and assets with unmatched accuracy, and enabling visibility and control of previously intractable business challenges.
Camrivox Ltd offers customers simple and effective Telephony Integration with CRM. The company has pioneered the development and delivery of Flexor Software, greatly simplifying CRM Telephony Integration that has traditionally relied upon large investments in infrastructure, hardware and support staff. With Flexor Software uniquely delivered and supported at the PC level, companies can bypass this resource-laden route, improving business processes and increasing customer satisfaction. Camrivox, founded in 2005, is headquartered in Cambridge, UK.
Nujira specializes in power amplifier technology for the wireless communications industry, focusing on high-efficiency solutions for 3G and fourth-generation cellular terminals, as well as digital broadcast transmitters. The company is known for its High Accuracy Tracking (HAT) Power Modulators, which help equipment manufacturers create smaller, more affordable, and energy-efficient base stations and transmitters. With a strong emphasis on envelope tracking technology, Nujira addresses the growing demands of operators and broadcasters by enhancing the performance and efficiency of broadband RF power amplifiers. The company holds over 200 patents related to envelope tracking, underscoring its commitment to innovation in the sector.
Metalysis Limited is a technology company based in Rotherham, United Kingdom, specializing in the manufacture of high-value metals and alloys, particularly titanium and tantalum. Founded in 2001, the company utilizes a solid-state process originally developed at the University of Cambridge to produce metal alloy powders that are primarily used in advanced manufacturing, aerospace, and automotive applications. This innovative process is designed to be more environmentally friendly and energy-efficient than traditional melting methods, providing clients with lower-cost solutions for producing 3D printable metal powders. Metalysis has established collaborations with various industrial and academic partners to enhance its production capabilities, including the Generation 4 technological expansion, which aims to scale up production to meet industrial demands. In addition to its manufacturing services, Metalysis also offers powder metallurgy, additives, and analytical services.
Phico Therapeutics Limited operates as a biotechnology company that primarily focuses on developing antibiotics to overcome antibacterial resistance. Its SASPject platform delivers anti-bacterial proteins, such as small acid-soluble spore proteins to selected bacterial species using targetable non-delivery vehicles. The company’s portfolio includes SASPject PT3, an antibiotic against Pseudomonas aeruginosa; SASPject PT4 and SASPject PT5 for systemic use against Klebsiella pneumonia and Escherichia coli; and SASPject PT1.2 that targets Staphylococcus aureus. Phico Therapeutics Limited was incorporated in 2000 and is based in Bourn, United Kingdom.
Phico Therapeutics Limited operates as a biotechnology company that primarily focuses on developing antibiotics to overcome antibacterial resistance. Its SASPject platform delivers anti-bacterial proteins, such as small acid-soluble spore proteins to selected bacterial species using targetable non-delivery vehicles. The company’s portfolio includes SASPject PT3, an antibiotic against Pseudomonas aeruginosa; SASPject PT4 and SASPject PT5 for systemic use against Klebsiella pneumonia and Escherichia coli; and SASPject PT1.2 that targets Staphylococcus aureus. Phico Therapeutics Limited was incorporated in 2000 and is based in Bourn, United Kingdom.